For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
Probing the Epigenome for Therapeutic Opportunities
Cheryl H. Arrowsmith, PhD
Chief Scientist, Structural Genomics Consortium; Professor, Department of Medical Biophysics; Senior Scientist, Ontario Cancer Institute / Princess Margaret Cancer Centre
University of Toronto